236 related articles for article (PubMed ID: 30783972)
1. Intravenous Infusion of AAV for Widespread Gene Delivery to the Nervous System.
Gessler DJ; Tai PWL; Li J; Gao G
Methods Mol Biol; 2019; 1950():143-163. PubMed ID: 30783972
[TBL] [Abstract][Full Text] [Related]
2. AAV-PHP.B Administration Results in a Differential Pattern of CNS Biodistribution in Non-human Primates Compared with Mice.
Liguore WA; Domire JS; Button D; Wang Y; Dufour BD; Srinivasan S; McBride JL
Mol Ther; 2019 Nov; 27(11):2018-2037. PubMed ID: 31420242
[TBL] [Abstract][Full Text] [Related]
3. Widespread Central Nervous System Gene Transfer and Silencing After Systemic Delivery of Novel AAV-AS Vector.
Choudhury SR; Harris AF; Cabral DJ; Keeler AM; Sapp E; Ferreira JS; Gray-Edwards HL; Johnson JA; Johnson AK; Su Q; Stoica L; DiFiglia M; Aronin N; Martin DR; Gao G; Sena-Esteves M
Mol Ther; 2016 Apr; 24(4):726-35. PubMed ID: 26708003
[TBL] [Abstract][Full Text] [Related]
4. In Vivo Selection Yields AAV-B1 Capsid for Central Nervous System and Muscle Gene Therapy.
Choudhury SR; Fitzpatrick Z; Harris AF; Maitland SA; Ferreira JS; Zhang Y; Ma S; Sharma RB; Gray-Edwards HL; Johnson JA; Johnson AK; Alonso LC; Punzo C; Wagner KR; Maguire CA; Kotin RM; Martin DR; Sena-Esteves M
Mol Ther; 2016 Aug; 24(7):1247-57. PubMed ID: 27117222
[TBL] [Abstract][Full Text] [Related]
5. A Safe and Reliable Technique for CNS Delivery of AAV Vectors in the Cisterna Magna.
Taghian T; Marosfoi MG; Puri AS; Cataltepe OI; King RM; Diffie EB; Maguire AS; Martin DR; Fernau D; Batista AR; Kuchel T; Christou C; Perumal R; Chandra S; Gamlin PD; Bertrand SG; Flotte TR; McKenna-Yasek D; Tai PWL; Aronin N; Gounis MJ; Sena-Esteves M; Gray-Edwards HL
Mol Ther; 2020 Feb; 28(2):411-421. PubMed ID: 31813800
[TBL] [Abstract][Full Text] [Related]
6. Expressing Transgenes That Exceed the Packaging Capacity of Adeno-Associated Virus Capsids.
Chamberlain K; Riyad JM; Weber T
Hum Gene Ther Methods; 2016 Feb; 27(1):1-12. PubMed ID: 26757051
[TBL] [Abstract][Full Text] [Related]
7. Gene transfer to the CNS using recombinant adeno-associated virus.
Stoica L; Ahmed SS; Gao G; Sena-Esteves M
Curr Protoc Microbiol; 2013; Chapter 14():14D.5.1-14D.5.18. PubMed ID: 23686825
[TBL] [Abstract][Full Text] [Related]
8.
Batista AR; King OD; Reardon CP; Davis C; Shankaracharya ; Philip V; Gray-Edwards H; Aronin N; Lutz C; Landers J; Sena-Esteves M
Hum Gene Ther; 2020 Jan; 31(1-2):90-102. PubMed ID: 31696742
[TBL] [Abstract][Full Text] [Related]
9. Vector Affinity and Receptor Distribution Define Tissue-Specific Targeting in an Engineered AAV Capsid.
Martino RA; Wang Q; Xu H; Hu G; Bell P; Arroyo EJ; Sims JJ; Wilson JM
J Virol; 2023 Jun; 97(6):e0017423. PubMed ID: 37199615
[TBL] [Abstract][Full Text] [Related]
10. The Neurotropic Properties of AAV-PHP.B Are Limited to C57BL/6J Mice.
Hordeaux J; Wang Q; Katz N; Buza EL; Bell P; Wilson JM
Mol Ther; 2018 Mar; 26(3):664-668. PubMed ID: 29428298
[TBL] [Abstract][Full Text] [Related]
11. Delivering Transgenic DNA Exceeding the Carrying Capacity of AAV Vectors.
Hirsch ML; Wolf SJ; Samulski RJ
Methods Mol Biol; 2016; 1382():21-39. PubMed ID: 26611576
[TBL] [Abstract][Full Text] [Related]
12. A comprehensive study of a 29-capsid AAV library in a non-human primate central nervous system.
Kondratov O; Kondratova L; Mandel RJ; Coleman K; Savage MA; Gray-Edwards HL; Ness TJ; Rodriguez-Lebron E; Bell RD; Rabinowitz J; Gamlin PD; Zolotukhin S
Mol Ther; 2021 Sep; 29(9):2806-2820. PubMed ID: 34298128
[TBL] [Abstract][Full Text] [Related]
13. High-Throughput Quantification of
Xu M; Li J; Xie J; He R; Su Q; Gao G; Tai PWL
Hum Gene Ther; 2019 Aug; 30(8):946-956. PubMed ID: 31072208
[TBL] [Abstract][Full Text] [Related]
14. Challenges in adeno-associated virus-based treatment of central nervous system diseases through systemic injection.
Huang L; Wan J; Wu Y; Tian Y; Yao Y; Yao S; Ji X; Wang S; Su Z; Xu H
Life Sci; 2021 Apr; 270():119142. PubMed ID: 33524419
[TBL] [Abstract][Full Text] [Related]
15. MRI-Guided Focused Ultrasound for Targeted Delivery of rAAV to the Brain.
Noroozian Z; Xhima K; Huang Y; Kaspar BK; Kügler S; Hynynen K; Aubert I
Methods Mol Biol; 2019; 1950():177-197. PubMed ID: 30783974
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-regulated, systemically delivered rAAV9: a step closer to CNS-restricted transgene expression.
Xie J; Xie Q; Zhang H; Ameres SL; Hung JH; Su Q; He R; Mu X; Seher Ahmed S; Park S; Kato H; Li C; Mueller C; Mello CC; Weng Z; Flotte TR; Zamore PD; Gao G
Mol Ther; 2011 Mar; 19(3):526-35. PubMed ID: 21179009
[TBL] [Abstract][Full Text] [Related]
17. Several rAAV vectors efficiently cross the blood-brain barrier and transduce neurons and astrocytes in the neonatal mouse central nervous system.
Zhang H; Yang B; Mu X; Ahmed SS; Su Q; He R; Wang H; Mueller C; Sena-Esteves M; Brown R; Xu Z; Gao G
Mol Ther; 2011 Aug; 19(8):1440-8. PubMed ID: 21610699
[TBL] [Abstract][Full Text] [Related]
18. Widespread transduction of astrocytes and neurons in the mouse central nervous system after systemic delivery of a self-complementary AAV-PHP.B vector.
Rincon MY; de Vin F; Duqué SI; Fripont S; Castaldo SA; Bouhuijzen-Wenger J; Holt MG
Gene Ther; 2018 Apr; 25(2):83-92. PubMed ID: 29523880
[TBL] [Abstract][Full Text] [Related]
19. Adeno-associated virus-mediated gene transfer to the brain: duration and modulation of expression.
Lo WD; Qu G; Sferra TJ; Clark R; Chen R; Johnson PR
Hum Gene Ther; 1999 Jan; 10(2):201-13. PubMed ID: 10022545
[TBL] [Abstract][Full Text] [Related]
20. Mapping the Structural Determinants Required for AAVrh.10 Transport across the Blood-Brain Barrier.
Albright BH; Storey CM; Murlidharan G; Castellanos Rivera RM; Berry GE; Madigan VJ; Asokan A
Mol Ther; 2018 Feb; 26(2):510-523. PubMed ID: 29175157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
